Metabolic Syndrome and Selective Inflammatory Markers in Psoriatic Patients. - Wikidata - wikimedia - TriplyDB

Metabolic Syndrome and Selective Inflammatory Markers in Psoriatic Patients.

Metabolic Syndrome and Selective Inflammatory Markers in Psoriatic Patients.

http://www.wikidata.org/entity/Q37554151

about

Clinical analysis of 84 cases of erythrodermic psoriasis and 121 cases of other types of erythroderma from 2010-2015.Psoriasis and Cardiovascular Risk-Do Promising New Biomarkers Have Clinical Impact?Systemic Inflammation, Oxidative Damage to Nucleic Acids, and Metabolic Syndrome in the Pathogenesis of Psoriasis.Changes in circulating cell-free DNA and nucleosomes in patients with exacerbated psoriasis.Serum levels of adipokines and cytokines in psoriasis patients: a systematic review and meta-analysis.The Pathophysiological Mechanisms and the Quest for Biomarkers in Psoriasis, a Stress-Related Skin Disease.The Clinical Significance and Potential Role of C-Reactive Protein in Chronic Inflammatory and Neurodegenerative Diseases.

P2860

Q40044223-11CDE0FF-1FDF-4A94-B94A-5954B3533473 Q41693144-6264AAC6-F6C9-484B-A1E8-DA5C8E310344 Q47606183-1F8F320B-28CC-4E9C-8C3E-1D9FE23E5E5F Q47658770-4241DCD7-34F4-4E43-9EAD-788D26D3B2FB Q49249983-DFDB9D49-F034-4174-ADCF-E8CFD7BE01D2 Q54956609-F49288DF-6419-472C-86AC-C789831449EB Q55373841-4FF9B758-883F-4258-BD89-A6CCD27D0E45

P2860

Metabolic Syndrome and Selective Inflammatory Markers in Psoriatic Patients.

http://www.wikidata.org/entity/Q37554151

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Metabolic Syndrome and Selective Inflammatory Markers in Psoriatic Patients.

@en

Metabolic Syndrome and Selective Inflammatory Markers in Psoriatic Patients.

@nl

type

label

Metabolic Syndrome and Selective Inflammatory Markers in Psoriatic Patients.

@en

Metabolic Syndrome and Selective Inflammatory Markers in Psoriatic Patients.

@nl

prefLabel

Metabolic Syndrome and Selective Inflammatory Markers in Psoriatic Patients.

@en

Metabolic Syndrome and Selective Inflammatory Markers in Psoriatic Patients.

@nl

P1433

Q37554151-3D50AD0A-9086-42B3-8046-31A7626E0CBA

P1476

Q37554151-EC6625EB-0180-4A84-ACC1-87DDB0A32EE6

P2093

Q37554151-3736E8E0-1EA5-45CF-96A8-DCC164710BE9

Q37554151-D73B8D6F-ACA2-45C7-9663-0C9D98EBE295

P2860

Q37554151-05E839D6-68B0-4F15-A2F5-7EEC98BD5771

Q37554151-07B159A4-3FB1-4AE8-BF27-CB11172224C2

Q37554151-08143BC4-7536-45BB-B434-E5492B6A66A0

Q37554151-197E4E67-22DE-4E6A-BBFA-86ADC371CB87

Q37554151-20AC5B4A-E651-4EEE-975B-E164DEAE74D4

Q37554151-2119867F-A99B-481C-975D-0A70C4CAC231

Q37554151-21A894D4-66F0-40D6-8E92-88B1E6488F8C

Q37554151-2567538B-137D-4563-AAC1-4EFE4C79B88E

Q37554151-28FA5B00-F455-41C6-9FD2-F32DA1E278B7

Q37554151-2CDF7625-3514-4257-AFEA-8D90522865D8

P304

Q37554151-2E06CD9B-806B-4A7E-B024-8DF2D118939F

P31

Q37554151-B475077A-1756-448E-9CC8-F2B69B70B1F3

P356

Q37554151-9E681FB1-8FED-4014-9692-EDD3607D5938

P478

Q37554151-B85D7726-67D3-418E-9F2C-27D006070C59

P50

Q37554151-170D85F5-F21E-4B52-A1E3-42A630710AAE

Q37554151-1BC83EA3-E2C5-4A56-979B-91BF0319574F

Q37554151-31C934F6-3766-4823-9D65-A55DD03AEEDE

Q37554151-60148E90-6345-47D6-A480-C51A52760153

Q37554151-8DB998EA-839D-4574-8B09-C5A8AEA09757

Q37554151-91B2CD13-D09F-4C5C-B7F1-5C1477123F53

Q37554151-ADF37299-75DB-409F-BD6F-5D2484BD7164

Q37554151-C78B4538-5648-4999-834F-1DA2555CF9C7

Q37554151-F0A27286-20A0-48E0-B0BA-A4095FC1FF0A

P577

Q37554151-7F07E6A8-B0EC-49AA-822D-A7C9CE01DA75

P698

Q37554151-08092277-BDE1-47A2-9B24-31D6E5FB490B

P921

Q37554151-1C262C52-EC0D-47EF-A0CD-45302FA375E4

Q37554151-B9D0F0F8-8B56-49AB-BA23-70BEB9D85151

P932

Q37554151-79BD55E0-DB1C-4950-9F07-2332A3ECD647

P356

P1433

Journal of Immunology Research

P1476

Metabolic Syndrome and Selective Inflammatory Markers in Psoriatic Patients.

@en

P2093

Simona Vachatova

http://www.w3.org/2001/XMLSchema#string

Vit Rehacek

http://www.w3.org/2001/XMLSchema#string

P2860

Oxidized phospholipids and lipoprotein-associated phospholipase A2 as important determinants of Lp(a) functionality and pathophysiological role

Resistin, an Adipokine with Non-Generalized Actions on Sympathetic Nerve Activity

Global epidemiology of psoriasis: a systematic review of incidence and prevalence

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Psoriasis: new comorbidities

The endocrine function of adipose tissue: an update

Serum leptin and adiponectin levels in Korean patients with psoriasis.

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.

Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.

Anti-psoriatic therapy recovers high-density lipoprotein composition and function.

P304

5380792

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2016/5380792

http://www.w3.org/2001/XMLSchema#string

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

Eva Čermáková

Andrea Málková

Miloslav Salavec

P577

2016-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28097156

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

P932

5209622

http://www.w3.org/2001/XMLSchema#string